Search
Now showing items 21-30 of 69
Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: A large retrospective study from the Royal Marsden Hospital
(2011)
Background: Despite the increasing use of positron emission tomography/computed tomography (PET/CT) in the management of patients with breast cancer, its role is yet to be defined. Patients and methods: We reviewed PET/CT ...
Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection
(2013)
Background: Patients with colorectal cancer (CRC) and liver metastases benefit from perioperative chemotherapy and liver resection. The potential benefit of adding bevacizumab is yet to be defined. The impact of bevacizumab ...
Molecular Classification of Breast Cancer
(2012)
This article reviews the conceptual and practical implications of the intrinsic subtype classification of breast cancers and the limitations of this approach. It presents the most extensively validated gene expression ...
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
(2009)
Background: Aggressive fibromatosis (AF) or desmoid tumour is a monoclonal proliferation which is locally invasive but does not metastasize. If local treatment fails to control the disease, systemic treatment with ...
Advanced aggressive fibromatosis: Effective palliation with chemotherapy
(2011)
Background. Aggressive fibromatosis (AF) is a locally invasive proliferative disease. The mainstay of treatment is surgery. Chemotherapy may be considered in inoperable AF following failure of hormonal therapy and/or NSAIDs. ...